BROOKSNSEBrooks Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 11 Apr · 17:48 IST

Please find enclosed copy of the certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Brooks Laboratories has filed a certificate issued under Regulation 74(5) of the SEBI Depositories Regulations, 2018. This is a routine compliance document where the company's Registrar and Transfer Agent (RTA) confirms to the depository that share certificates received for dematerialisation (converting physical shares into electronic form) have been processed and accounted for. No specific numbers on share movement or financial figures are disclosed in this filing, as it is purely a procedural submission. This type of filing is made periodically by listed companies as part of their ongoing compliance obligations with SEBI and depositories such as NSDL or CDSL.

Likely market impact

This is a routine regulatory compliance filing with no material impact on the company's financials, operations, or stock price. Shareholders need not take any action.